These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4780810)

  • 1. Aminoglycoside antibiotics. II. Configurational and positional isomers of BB-K8.
    Naito T; Nakagawa S; Abe Y; Toda S; Fujisawa K
    J Antibiot (Tokyo); 1973 May; 26(5):297-301. PubMed ID: 4780810
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro studies of BB-K8, a new aminoglycoside antibiotic.
    Bodey GP; Stewart D
    Antimicrob Agents Chemother; 1973 Aug; 4(2):186-92. PubMed ID: 4790938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on amikacin (BB-K8), a new aminoglycoside antibiotic (author's transl)].
    Kawano M; Irimajiri K; Higuchi J; Uchiyama T; Tsubura E
    Jpn J Antibiot; 1974 Aug; 27(4):446-50. PubMed ID: 4436954
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on a new aminoglycoside antibiotic, amikacin (BB-K8) in pediatrics (author's transl)].
    Nakazawa S; Sato H; Watanabe O; Fujii N; Oka S
    Jpn J Antibiot; 1974 Aug; 27(4):438-45. PubMed ID: 4215904
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibacterial activity of a new semisynthetic aminoglycoside antibiotic amikacin (BB-K8) (author's transl)].
    Mitsuhashi S; Kawabe H; Iyobe S; Tanaka T; Inoue M
    Jpn J Antibiot; 1974 Apr; 27(2):189-92. PubMed ID: 4211300
    [No Abstract]   [Full Text] [Related]  

  • 6. BB-K 8, a new semisynthetic aminoglycoside antibiotic.
    Kawaguchi H; Naito T; Nakagawa S; Fujisawa KI
    J Antibiot (Tokyo); 1972 Dec; 25(12):695-708. PubMed ID: 4568692
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods.
    Klastersky J; Nyamubeya B; Vandenborre L
    J Med Microbiol; 1974 Nov; 7(4):465-72. PubMed ID: 4217836
    [No Abstract]   [Full Text] [Related]  

  • 8. Syntheses and properties of the 6"-deoxy or 4",6"-dideoxy derivatives of the kanamycin antibiotics.
    Miyasaka T; Ikeda D; Kondo S; Umezawa H
    J Antibiot (Tokyo); 1980 May; 33(5):527-32. PubMed ID: 7429979
    [No Abstract]   [Full Text] [Related]  

  • 9. [Laboratory and clinical studies on amikacin (BB-K8), a new semisynthetic aminoglycoside (author's transl)].
    Isogai K; Shimizu Y; Kawada Y; Nishiura T
    Jpn J Antibiot; 1974 Jun; 27(3):328-36. PubMed ID: 4140246
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the microbiological activity in vitro of BB-K-8, a new aminoglycoside antibiotic].
    Ravagnan G; Rasura M; Piccolomini R
    Boll Soc Ital Biol Sper; 1976 Sep; 52(18):1440-6. PubMed ID: 1024552
    [No Abstract]   [Full Text] [Related]  

  • 11. [Laboratory and clinical evaluation of amikacin (BB-K8) (author's transl)].
    Gonda N; Shimada S; Fujimori I; Katsu M; Miyazaki R
    Jpn J Antibiot; 1974 Oct; 27(5):620-4. PubMed ID: 4617008
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria.
    Kondo S; Iinuma K; Yamamoto H; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1973 Jul; 26(7):412-5. PubMed ID: 4782059
    [No Abstract]   [Full Text] [Related]  

  • 14. [Laboratory and clinical investigation on amikacin (BB-K8) in complicated infections of the urological field (author's transl)].
    Kondo K; Amano M; Niijima T
    Jpn J Antibiot; 1974 Apr; 27(2):226-33. PubMed ID: 4546628
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues.
    Li J; Wang J; Czyryca PG; Chang H; Orsak TW; Evanson R; Chang CW
    Org Lett; 2004 Apr; 6(9):1381-4. PubMed ID: 15101747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside antibiotics. XII. Effect of N-alkylation in kanamycin antibiotics.
    Nakagawa S; Toda S; Abe Y; Yamashita H; Fujisawa KI; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1978 Jul; 31(7):675-80. PubMed ID: 690002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on amikacin (BB-K8) (author's transl)].
    Seiga K; Minagawa M; Furuta N; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1974 Aug; 27(4):434-7. PubMed ID: 4215903
    [No Abstract]   [Full Text] [Related]  

  • 18. [[Fundamental and clinical studies of amikacin (BB-K8) in surgical field (author's transl)]?].
    Shibata K; Fugii M; Shinagawa N; Suzuki Y; Muramatsu
    Jpn J Antibiot; 1974 Oct; 27(5):625-32. PubMed ID: 4218270
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
    Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
    J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some chemical modifications of aminoglycoside antibiotics.
    Kondo S
    Jpn J Antibiot; 1979 Dec; 32 Suppl():S228-36. PubMed ID: 398905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.